Clinical Trial Update: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 study of AB598 as monotherapy and in combination across multiple advanced cancers is ongoing, with status active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervical Cancer
• Esophageal Cancer
• Gastric Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Renal Cell Carcinoma
• Triple-negative Breast Cancer

Drugs mentioned

• AB598

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Advanced Cancer, Advanced Malignancies | Phase 1 | Status: ACTIVE_NOT_RECRUITING